Gout
Gout
Advertisement
Charlotte RobinsonGout | May 20, 2024
Recognizing and managing concurrent gout and CKD is important for improving outcomes but can be difficult.
Read More
Victoria SochaGout | March 30, 2024
There are few data available on the associations between serum urate levels and the risk of recurrent gout.
Cailin ConnerGout | December 12, 2023
A study found notable lipid profile changes in hyperuricemia and early-onset gout.
Cailin ConnerGout | December 9, 2023
Pharmacologic activation of Nrf2 alleviates gout by inhibiting oxidative stress, reducing joint inflammation.
Cailin ConnerGout | December 8, 2023
Metabolic syndrome is strongly linked to hyperuricemia in both genders, especially in women.
Cailin ConnerGout | December 8, 2023
Blood metabolites, particularly hexadecanedioate, are found to have a causal link to a reduced risk of gout.
Cailin ConnerGout | December 7, 2023
Elevated serum uric acid levels and the presence of gout are associated with an increased risk of colorectal cancer.
Cailin ConnerGout | February 5, 2024
Differences in psoriatic arthritis symptoms are evident between patients with and without hyperuricemia.
Cailin ConnerGout | February 5, 2024
Endovascular interventional procedures significantly increase the risk of gout flares in the postsurgical period.
Cailin ConnerGout | February 5, 2024
Utilizing DECT showed that achieving a lower serum urate of <5.0 mg/dL leads to more extensive dissolution of MSU ...
Cailin ConnerGout | February 5, 2024
Autoimmune hypothyroidism and autoimmune hyperthyroidism have a causal association with an increased risk of gout.
Cailin ConnerGout | November 9, 2023
A recent study showed that patients with gout, CVD, CKD, and cancer had the highest risk of gout flares.
Cailin ConnerGout | November 9, 2023
Gout significantly increases the risk of all-cause mortality and mortality due to specific causes.
Cailin ConnerGout | February 5, 2024
Metformin use was associated with reduced urate levels and a decreased risk of hyperuricemia.
Cailin ConnerGout | November 8, 2023
Patients with chronic inflammatory diseases face a significantly increased risk of developing post-thrombotic syndrome.
Cailin ConnerGout | November 8, 2023
Patient characteristics significantly impact serum urate goal achievement during urate-lowering therapy.
Victoria SochaASN Kidney Week 2023 | February 5, 2024
Examining the potential benefits of pegloticase treatment in patients with CKD with refractory gout.
Victoria SochaASN Kidney Week 2023 | February 5, 2024
Blood pressure decreased during pegloticase therapy in chronic kidney disease (CKD) and non-CKD patients.
Cailin ConnerGout | October 11, 2023
There is a significant association between inflammatory bowel disease, particularly Crohn’s disease, and gout.
Cailin ConnerGout | February 5, 2024
Tophi, as detected by ultrasound, was independently associated with impaired kidney function.
Advertisement
Advertisement
Advertisement
Latest News

May 29, 2024